Viewing Study NCT04281420


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT04281420
Status: TERMINATED
Last Update Posted: 2024-04-30
First Post: 2020-02-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Sponsor: Antengene Therapeutics Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module